"Real world" eligibility for aducanumab

被引：28
|
作者：
Canevelli, Marco [1 ,2 ]
Rossi, Paolo Dionigi [3 ]
Astrone, Paolo [4 ]
Consorti, Ernesto [5 ]
Vanacore, Nicola [2 ]
Cesari, Matteo [6 ,7 ]
机构：
[1] Sapienza Univ, Dept Human Neurosci, Viale Univ 30, I-00185 Rome, Italy
[2] Natl Inst Hlth, Natl Ctr Dis Prevent & Hlth Promot, Rome, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Geriatr Unit, Milan, Italy
[4] Azienda Socio Sanit Terr ASST Lodi, Subacute Care Unit, Lodi, Italy
[5] Univ Milan, Geriatr & Gerontol, Milan, Italy
[6] IRCCS Ist Clin Sci Maugeri, Geriatr Unit, Milan, Italy
[7] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2021年 / 69卷 / 10期
关键词：
D O I：
10.1111/jgs.17390
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：2995 / 2998
页数：4
相关论文
共 50 条
  • [1] "Real-world" eligibility for aducanumab depends on clinical setting and patients' journey
    Padovani, Alessandro
    Caratozzolo, Salvatore
    Rozzini, Luca
    Pilotto, Andrea
    Benussi, Alberto
    Tedeschi, Gioacchino
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (02) : 626 - 628
  • [2] Diversifying Eligibility to Enhance Real-World Results
    Fayyaz, Fatima
    Carvajal, Richard D.
    Devoe, Craig E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (23) : 3895 - +
  • [3] Unveiling the eligibility for screening of cardiac amyloidosis in a real world population
    Filipa Gerardo, F.
    Saca, C.
    Monteiro, A.
    Santos, P.
    Carvalho, C.
    Passos, M.
    Fialho, I.
    Mateus, C.
    Miranda, I.
    Roque, D.
    Faria, D.
    Ribeiro, R.
    Loureiro, J.
    Augusto, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 475 - 475
  • [4] ELIGIBILITY COAPT TRIAL IN DAILY PRACTICE: A REAL WORLD EXPERIENCE
    Zancanaro, E.
    Buzzatti, N.
    Denti, P.
    Maisano, F.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : D44 - D44
  • [5] Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population
    Hakansson, Erik
    Norberg, Helena
    Sjalander, Sara
    Lindmark, Krister
    CARDIOVASCULAR THERAPEUTICS, 2021, 2021
  • [6] Eligibility to COAPT Trial in the Daily Practice: A Real-World Experience
    Zancanaro, Edoardo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B135 - B136
  • [7] Generalisability of Common Oncology Clinical Trial Eligibility Criteria in the Real World
    Karim, S.
    Xu, Y.
    Kong, S.
    Abdel-Rahman, O.
    Quan, M. L.
    Cheung, W. Y.
    CLINICAL ONCOLOGY, 2019, 31 (09) : E160 - E166
  • [8] Eligibility to COAPT trial in the daily practice: A real-world experience
    Zancanaro, Edoardo
    Buzzatti, Nicola
    Denti, Paolo
    Guicciardi, Nicolo Azzola
    Melillo, Enrico
    Monaco, Fabrizio
    Agricola, Eustachio
    Ancona, Francesco
    Alfieri, Ottavio
    De Bonis, Michele
    Maisano, Francesco
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2024, 104 (02) : 368 - 377
  • [9] Eligibility for Dapagliflozin and Empagliflozin in a Real-world Heart Failure Population
    Thorvaldsen, Tonje
    Ferrannini, Giulia
    Mellbin, Linda
    Benson, Lina
    Cosentino, Francesco
    Mcmurray, John J., V
    Dahlstrom, Ulf
    Lund, Lars H.
    Savarese, Gianluigi
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (07) : 1050 - 1062
  • [10] Eligibility for acetazolamide in real-world acute heart failure patients
    Gerardo, A.
    Fialho, I.
    Passos, M.
    Miranda, I.
    Mateus, C.
    Beringuilho, M.
    Lopes, J.
    Faria, D.
    Roque, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 164 - 164
12345